Dysregulated micro-RNAs and long noncoding RNAs in cardiac development and pediatric heart failure

Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1308-H1315. doi: 10.1152/ajpheart.00511.2019. Epub 2020 Mar 27.

Abstract

Noncoding RNAs (ncRNAs) are broadly described as RNA molecules that are not translated into protein. The investigation of dysregulated ncRNAs in human diseases such as cancer, neurological, and cardiovascular diseases has been under way for well over a decade. Micro-RNAs and long noncoding RNAs (lncRNAs) are the best characterized ncRNAs. These ncRNAs can have profound effects on the regulation of gene expression during cardiac development and disease. Importantly, ncRNAs are significant regulators of gene expression in several congenital heart diseases and can positively or negatively impact cardiovascular development. In this review, we focus on literature involving micro-RNAs and lncRNAs in the context of pediatric cardiovascular diseases, preclinical models of heart failure, and cardiac development.

Keywords: cardiac development; heart failure; long noncoding RNA; micro-RNA; pediatric.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Gene Expression Regulation, Developmental*
  • Heart / embryology
  • Heart Defects, Congenital / genetics*
  • Heart Defects, Congenital / metabolism
  • Heart Defects, Congenital / pathology
  • Heart Failure / genetics*
  • Heart Failure / metabolism
  • Heart Failure / pathology
  • Humans
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Myocardium / metabolism*
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / metabolism

Substances

  • MicroRNAs
  • RNA, Long Noncoding